<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03674853</url>
  </required_header>
  <id_info>
    <org_study_id>KY20172099-1</org_study_id>
    <nct_id>NCT03674853</nct_id>
  </id_info>
  <brief_title>The Study of Wuling Capsule in Treatment Chronic Tinnitus</brief_title>
  <official_title>Clinical Study of Wuling Capsule in the Treatment of Chronic Tinnitus With Emotional Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of psychological/mental factors on the severity of subjective
      tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic
      subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus
      complications, such as depression, anxiety and insomnia, and the improvement of
      patients'quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 12, 2018</start_date>
  <completion_date type="Anticipated">May 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>THI</measure>
    <time_frame>8 weeks</time_frame>
    <description>tinnitus handicap index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HAMA</measure>
    <time_frame>8 weeks</time_frame>
    <description>Hamilton anxiety scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HAMD</measure>
    <time_frame>8 weeks</time_frame>
    <description>Hamilton depression scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Tinnitus, Subjective</condition>
  <arm_group>
    <arm_group_label>Wuling Capsule group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who were treated with Wuling Caspule</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oryzanol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who were treated with oryzanol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Wuling Capsule</intervention_name>
    <description>take Wuling Capsule in experiment group for 2 months</description>
    <arm_group_label>Wuling Capsule group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oryzanol</intervention_name>
    <description>take oryzanol in active comparator group for 2 months</description>
    <arm_group_label>Oryzanol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tinnitus with a history longer than 6 months;

          -  7 &lt; HAMD score &lt; 24 and / or 7 &lt; HAMA score &lt; 21;

          -  No antianxiety, depression or antipsychotic treatment within 2 weeks.

        Exclusion Criteria:

          -  objective tinnitus;

          -  tinnitus with defined causes;

          -  accompanied with acute infection, acute trauma, perioperative, chronic disease in the
             acute stage;

          -  with mental illness family history;

          -  HAMD score greater than 24 points or HAMA score greater than 21 points;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zha Dingjun, doctor</last_name>
    <role>Study Chair</role>
    <affiliation>First Affiliated Hospital of Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Song Yongli, doctor</last_name>
    <phone>+86 02984775386</phone>
    <email>syljudy@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Song Yongli, doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>September 13, 2018</study_first_submitted>
  <study_first_submitted_qc>September 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2018</study_first_posted>
  <last_update_submitted>September 14, 2018</last_update_submitted>
  <last_update_submitted_qc>September 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gamma-oryzanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

